Accuryn Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.2M

  • Investors
  • 1

Accuryn General Information

Description

Developer of predictive health monitoring system designed to improve patient care using artificial intelligence and machine insights. The company's platform provides real-time measurement of intra-abdominal pressure, urine output, and core body temperature in degrees Fahrenheit and degrees Celcius, enabling medical teams to predict adverse outcomes in critical care settings better.

Contact Information

Website
www.accuryn.com
Formerly Known As
Consano Medica, ConsanoMed
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 26142 Eden Landing Road
  • Hayward, CA 94545
  • United States
+1 (888)
Primary Industry
Monitoring Equipment
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 26142 Eden Landing Road
  • Hayward, CA 94545
  • United States
+1 (888)

Accuryn Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accuryn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 31-Oct-2024 $3.2M Completed Generating Revenue
12. Bankruptcy: Admin/Reorg 01-Dec-2023 Completed Bankruptcy: Admin/Reorg
11. Accelerator/Incubator Completed Generating Revenue
10. Later Stage VC (Series D) 24-Mar-2023 Completed Generating Revenue
9. Later Stage VC (Series C3) 21-Aug-2020 Completed Generating Revenue
8. Debt - PPP 14-Apr-2020 Completed Generating Revenue
7. Later Stage VC (Series C2) 20-Dec-2019 Completed Generating Revenue
6. Accelerator/Incubator 01-Jun-2019 Completed Generating Revenue
5. Later Stage VC (Series C) 28-Feb-2019 $29.4M $42.5M Completed Generating Revenue
4. Later Stage VC (Series B) 31-Aug-2018 $8.2M $13.1M Completed Startup
To view Accuryn’s complete valuation and funding history, request access »

Accuryn Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D-2
Series D-1
Series C3
Series C2
Series C
Series B 8,457,337 $0.000100 $0.03 $1.12 $1.12 1x $1.12 1.51%
Series A 12,241,634 $0.000100 $0.03 $0.49 $0.49 1x $0.49 2.19%
To view Accuryn’s complete cap table history, request access »

Accuryn Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of predictive health monitoring system designed to improve patient care using artificial intelligence and mach
Monitoring Equipment
Hayward, CA
42 As of 2025

Zhongshan, China
 

Jerusalem, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Accuryn Competitors (8)

One of Accuryn’s 8 competitors is Guangdong Transtek Medical Electronics Company, a Formerly VC-backed company based in Zhongshan, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Guangdong Transtek Medical Electronics Company Formerly VC-backed Zhongshan, China
RenalSense Venture Capital-Backed Jerusalem, Israel
Boston Scientific Corporation Marlborough, MA
BD Medical Segment (Ophthalmic Systems Unit) Formerly PE-Backed Franklin Lakes, NJ
Google DeepMind Venture Capital-Backed London, United Kingdom
You’re viewing 5 of 8 competitors. Get the full list »

Accuryn Patents

  • 113

    Total Documents Applications and Grants

  • Total Patents Families

  • 70

    Granted

  • 37

    Pending

  • Expiring in next 12 mo

Accuryn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240099624-A1 Systems, devices and methods for draining and analyzing bodily fluids, pressures and assessing health Pending 16-Jun-2021
AU-2022213307-A1 Equipment adaptor assembly and equipment stand Pending 26-Jan-2021
AU-2022213307-A9 Equipment adaptor assembly and equipment stand Pending 26-Jan-2021
CA-3204741-A1 Equipment adaptor assembly and equipment stand Pending 26-Jan-2021
EP-4262674-A1 Equipment adaptor assembly and equipment stand Pending 26-Jan-2021 A61G13/102
To view Accuryn’s complete patent history, request access »

Accuryn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accuryn Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ceros Capital Markets Venture Capital Minority
To view Accuryn’s complete investors history, request access »

Accuryn Investments (1)

Accuryn’s most recent deal was a Later Stage VC with Centese for . The deal was made on 13-Mar-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Centese 13-Mar-2020 Later Stage VC Surgical Devices
To view Accuryn’s complete investments history, request access »

Ready to get started?

Request a free trial

Accuryn FAQs

  • When was Accuryn founded?

    Accuryn was founded in 2011.

  • Where is Accuryn headquartered?

    Accuryn is headquartered in Hayward, CA.

  • What is the size of Accuryn?

    Accuryn has 42 total employees.

  • What industry is Accuryn in?

    Accuryn’s primary industry is Monitoring Equipment.

  • Is Accuryn a private or public company?

    Accuryn is a Private company.

  • What is Accuryn’s current revenue?

    The current revenue for Accuryn is .

  • How much funding has Accuryn raised over time?

    Accuryn has raised $111M.

  • Who are Accuryn’s investors?

    Ceros Capital Markets has invested in Accuryn.

  • Who are Accuryn’s competitors?

    Guangdong Transtek Medical Electronics Company, RenalSense, Boston Scientific, BD Medical Segment (Ophthalmic Systems Unit), and Google DeepMind are some of the 8 competitors of Accuryn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »